Your browser doesn't support javascript.
loading
Comparison of HIV Indicators after the Implementation of a New Model for TB and HIV Management in an Iranian Prison.
Farhoudi, Behnam; SeyedAlinaghi, SeyedAhmad; Ataeinia, Bahar; Hosseini, Mostafa; Jafari, Sirous; Alasvand, Ramin; Tashakoriyan, Mehrzad; Mohraz, Minoo.
Afiliação
  • Farhoudi B; Clinical Research Development Center, Islamic Azad University, Tehran, Iran.
  • SeyedAlinaghi S; Iranian Research Center for HIV/AIDS, Tehran University of Medical Sciences, Tehran, Iran.
  • Ataeinia B; Iranian Research Center for HIV/AIDS, Tehran University of Medical Sciences, Tehran, Iran.
  • Hosseini M; School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
  • Jafari S; Iranian Research Center for HIV/AIDS, Tehran University of Medical Sciences, Tehran, Iran.
  • Alasvand R; The Health and Treatment Office, Iranian Prisons Organization, Tehran, Iran.
  • Tashakoriyan M; The Health and Treatment Office, Iranian Prisons Organization, Tehran, Iran.
  • Mohraz M; Iranian Research Center for HIV/AIDS, Tehran University of Medical Sciences, Tehran, Iran.
Infect Disord Drug Targets ; 20(6): 778-783, 2020.
Article em En | MEDLINE | ID: mdl-31613730
ABSTRACT

OBJECTIVES:

A new national clinical guideline for the management of tuberculosis and HIV in Iranian prisons was released in 2011. The aim of this study was to compare HIV indicators in the case and control prisons after implementation of the new guideline.

METHODS:

This report examines outcomes observed during the pilot phase of its implementation at a case prison from October 2013 to June 2014 compared to a control prison that had not yet implemented the guideline. The case prison included incarcerated individuals in the Great Tehran Prison. A prison in Alborz province was considered as a control group. Pearson's Chi-squared, two-sample t-test, paired t-test and Kruskal-Wallis were used for the analysis.

RESULTS:

The intervention significantly increased the total number of inmates tested for HIV and of diagnoses of HIV-positive inmates in the case prison compared to the control prison (P<0.001). Moreover, coverage of antiretroviral therapy was higher in the case prison compared to the control prison (P=0.015).

CONCLUSION:

We recommend the implementation of this guideline in all Iranian prisons.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 / 3_ND Base de dados: MEDLINE Assunto principal: Prisioneiros / Infecções por HIV Tipo de estudo: Guideline Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Infect Disord Drug Targets Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 / 3_ND Base de dados: MEDLINE Assunto principal: Prisioneiros / Infecções por HIV Tipo de estudo: Guideline Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Infect Disord Drug Targets Ano de publicação: 2020 Tipo de documento: Article